Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · IEX Real-Time Price · USD
3.650
-0.050 (-1.35%)
At close: May 17, 2024, 4:00 PM
3.750
+0.100 (2.74%)
After-hours: May 17, 2024, 5:08 PM EDT
Atea Pharmaceuticals Market Cap
Atea Pharmaceuticals has a market cap or net worth of $308.26 million as of May 17, 2024. Its market cap has increased by 11.65% in one year.
Market Cap
308.26M
Enterprise Value
-231.02M
1-Year Change
11.65%
Ranking
Category
Stock Price
$3.65
Market Cap Chart
Since the IPO on October 30, 2020, Atea Pharmaceuticals's market cap has decreased from $1.94B to $308.26M, a decrease of -84.09%. That is a compound annual growth rate of -40.44%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 307.40M | -1.35% |
May 16, 2024 | 311.60M | -0.29% |
May 15, 2024 | 312.50M | -6.30% |
May 14, 2024 | 333.50M | -1.91% |
May 13, 2024 | 340.00M | 3.85% |
May 10, 2024 | 327.40M | -1.03% |
May 9, 2024 | 330.80M | - |
May 8, 2024 | 330.80M | -0.24% |
May 7, 2024 | 331.60M | -1.51% |
May 6, 2024 | 336.70M | 1.02% |
May 3, 2024 | 333.30M | 3.38% |
May 2, 2024 | 322.40M | -0.49% |
May 1, 2024 | 324.00M | 4.05% |
Apr 30, 2024 | 311.40M | -0.29% |
Apr 29, 2024 | 312.30M | - |
Apr 26, 2024 | 312.30M | 0.55% |
Apr 25, 2024 | 310.60M | -0.26% |
Apr 24, 2024 | 311.40M | -0.80% |
Apr 23, 2024 | 313.90M | 1.62% |
Apr 22, 2024 | 308.90M | -1.34% |
Apr 19, 2024 | 313.10M | 0.55% |
Apr 18, 2024 | 311.40M | -0.29% |
Apr 17, 2024 | 312.30M | -0.79% |
Apr 16, 2024 | 314.80M | -0.54% |
Apr 15, 2024 | 316.50M | - |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
DocGo | 313.33M |
Inovio Pharmaceuticals | 311.71M |
Treace Medical Concepts | 311.27M |
Kamada | 310.94M |
Poseida Therapeutics | 310.26M |
Caribou Biosciences | 307.07M |
XOMA Corporation | 299.00M |
SOPHiA GENETICS | 298.43M |